Cargando…
Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients
BACKGROUND: Atrial fibrillation (AF) is the most frequent tachyarrhythmia in patients with a permanent pacemaker. Angiotensin II receptor antagonists have a protective effect against the occurrence of AF in patients with heart diseases. This study aimed to assess the effectiveness of olmesartan in t...
Autores principales: | Zhang, Hang, Pan, Chang, Zhang, Juan, Zhu, Lin-Lin, Huang, Kai, Zhong, Yun, Hu, Zuo-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022331/ https://www.ncbi.nlm.nih.gov/pubmed/27625082 http://dx.doi.org/10.4103/0366-6999.189924 |
Ejemplares similares
-
Incidence and predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular block and dual chamber pacemaker implantation
por: Radeljić, Vjekoslav, et al.
Publicado: (2011) -
Analyses of risk factors and prognosis for new-onset atrial fibrillation in elderly patients after dual-chamber pacemaker implantation
por: Chen, Xiao-Li, et al.
Publicado: (2018) -
One stage atrioventricular nodal ablation and leadless pacemaker implantation for refractory atrial fibrillation
por: Lau, Chu‐Pak, et al.
Publicado: (2018) -
Association between routine biomarkers and atrial fibrillation in patients undergoing implantation of a dual‐chamber pacemaker
por: Kyrlas, Konstantinos, et al.
Publicado: (2020) -
Atrial fibrillation burden in Myotonic
Dystrophy type 1 patients implanted
with dual chamber pacemaker:
the efficacy of the overdrive atrial algorithm
at 2 year follow-up
por: RUSSO, VINCENZO, et al.
Publicado: (2013)